Explore
← New search
Filters:
Hangzhou DAC Biotech (China)
✕
medium
✕
cd45+ immune cells from resected tumors of 7 nsclc patients (6 napc, 1 nac)
✕
clear all
1 matching publication(s)
PD-1 blockade potentiates neoadjuvant chemotherapy in NSCLC via increasing CD127+ and KLRG1+ CD8 T cells.
PMID 37231145 · NPJ Precis Oncol · 2023
L1
40/100